Novartis Ag (NVS) Enterprise Value (2009 - 2026)
Novartis Ag (NVS) reported Enterprise Value of $289.53 billion for Q2 2026, up 25.7% from $230.35 billion a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Enterprise Value (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Enterprise Value came in at $254.92 billion, up 32.7% year-over-year; for FY2025, it came in at $249.71 billion, up 39.7% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- By year, Enterprise Value came in at $178.8 billion in FY2024 (-6.1%), $190.47 billion in FY2023 (+4.4%), $182.44 billion in FY2022 (+9.0%) and $167.33 billion in FY2021 (-16.6%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value in data going back to Q1 2009.
- Year over year, Enterprise Value has now increased in each of the last six quarters, with growth averaging 17.1% over the last eight quarters.
- The high point for year-over-year Enterprise Value in five years was Q4 2025 (growth of 39.7%); the low point was Q4 2021 (a decline of 16.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $282.68 billion (Q1 2026), $249.71 billion (Q4 2025) and $242.08 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 289.53 Bn |
| Mar 31, 2026 | 282.68 Bn |
| Dec 31, 2025 | 249.71 Bn |
| Sep 30, 2025 | 242.08 Bn |
| Jun 30, 2025 | 230.35 Bn |
| Mar 31, 2025 | 211.22 Bn |
| Dec 31, 2024 | 178.80 Bn |
| Sep 30, 2024 | 219.53 Bn |
| Jun 30, 2024 | 207.85 Bn |
| Mar 31, 2024 | 185.84 Bn |
| Dec 31, 2023 | 190.47 Bn |
| Sep 30, 2023 | 201.66 Bn |
| Jun 30, 2023 | 200.78 Bn |
| Mar 31, 2023 | 180.66 Bn |
| Dec 31, 2022 | 182.44 Bn |
| Sep 30, 2022 | 158.88 Bn |
| Jun 30, 2022 | 182.96 Bn |
| Mar 31, 2022 | 179.72 Bn |
| Dec 31, 2021 | 167.33 Bn |
| Sep 30, 2021 | 174.51 Bn |
API Access
Novartis Ag Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();